News

Laura Wingler, PhD, assistant professor of pharmacology and cancer biology, has been named a 2022 Pew Scholar in the Biomedical Sciences. The award provides four years of funding to early-career scientists to explore some of the most pressing questions in health and medicine. Wingler is one of 22 scholars to receive the award this year.

Kastan is a pediatric hematologist-oncologist and renowned cancer biologist who has made numerous seminal discoveries in elucidating pathways involved in DNA damage signaling. His discoveries have made a major impact on our understanding of both how cancers develop and how they respond to chemotherapy and radiation therapy.

Duke University School of Medicine was awarded more than $608 million in federal funding from the National Institutes of Health (NIH) in 2021, ranking third nationally among academic medical centers, up from 10th last year, according to the Blue Ridge Institute for Medical Research.

While most of his bioscience colleagues around the world are studying the 23,000 protein-coding genes that make us human, Zhao Zhang, PhD — ZZ to just about everyone, is looking at the other part of the genome and asking what it does.

In a study appearing online Aug. 24 in the journal Nature Communications, a research team led by the Duke Cancer Institute has identified the mechanisms at work, describing how breast cancer cells use cholesterol to develop tolerance to stress, making them impervious to death as they migrate from the original tumor site.

The Peer Mentor Network is a resource that connects 11 current PhD student volunteer mentors with the approximately 100 incoming PhD students who will be located in one of the School’s 17 departments in Fall 2021.

Nine faculty members in the Duke University School of Medicine have been awarded distinguished professorships. In total, Duke University awarded distinguished professors to 22 faculty members from eight Duke colleges and schools this year. Distinguished professorships are awarded to faculty who have demonstrated extraordinary scholarship in advancing science and improving human health.

The award provides four years of exploratory research funding to young investigators of outstanding promise as they investigate timely questions surrounding health and disease. Zhang is one of 22 scholars to receive the award this year.

My research interests include pharmacogenomics, epigenomics, molecular biology and their respective translational and clinical applications in precision medicine.

The American Association for Cancer Research (AACR) has named Jen-Tsan Ashley Chi, MD, PhD, as co-winner of the Molecular Cancer Research Michael B. Kastan Award for Research Excellence on behalf of his all-Duke research team for their paper — A TAZ-ANGPTL4-NOX2 Axis Regulates Ferroptotic Cell Death and Chemoresistance in Epithelial Ovarian Cancer.